Therefore, to understand whether cDC1 or macrophage Mbd2 deficiency was important for the increased susceptibility of Mbd2−/− mice to DSS colitis, we performed microarray analysis on purified CD11b−CD103+ DCs and macrophages from WT and Mbd2−/− DSS treated mice. The gene discussed is MBD2; the disease is colitis.